Kestra Medical Technologies, Ltd.
KMTS
$21.27
$0.864.21%
| 10/31/2024 | 07/31/2024 | ||||
|---|---|---|---|---|---|
| Net Income | 19.84% | 19.84% | |||
| Total Depreciation and Amortization | -9.61% | -9.61% | |||
| Total Amortization of Deferred Charges | 304.23% | 304.23% | |||
| Total Other Non-Cash Items | -31.10% | -31.10% | |||
| Change in Net Operating Assets | -1,484.54% | -1,484.54% | |||
| Cash from Operations | 14.38% | 14.38% | |||
| Capital Expenditure | -243.32% | -243.32% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -269.86% | -269.86% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | 106.80% | 106.80% | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | 637.33% | 637.33% | |||
| Cash from Financing | 115.85% | 115.85% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 663.33% | 663.33% | |||
